Connection
Robert Page to Clinical Trials as Topic
This is a "connection" page, showing publications Robert Page has written about Clinical Trials as Topic.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.068 |
|
|
|
-
Abrol R, Page RL. Azimilide dihydrochloride: a new class III anti-arrhythmic agent. Expert Opin Investig Drugs. 2000 Nov; 9(11):2705-15.
Score: 0.033
-
Slejko JF, Page RL, Sullivan PW. Cost-effectiveness of statin therapy for vascular event prevention in adults with elevated C-reactive protein: implications of JUPITER. Curr Med Res Opin. 2010 Oct; 26(10):2485-97.
Score: 0.016
-
Lindenfeld J, Miller GG, Shakar SF, Zolty R, Lowes BD, Wolfel EE, Mestroni L, Page RL, Kobashigawa J. Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs. Circulation. 2004 Dec 21; 110(25):3858-65.
Score: 0.011
-
Welch PJ, Page RL, Hamdan MH. Management of ventricular arrhythmias: a trial-based approach. J Am Coll Cardiol. 1999 Sep; 34(3):621-30.
Score: 0.008